What this articles addresses, e.g., the differential diagnosis of CAPS, is something I brought up a long time ago, especially at the Galveston APS meeting a few years ago. In this regard, when talking about the longstanding CAPS registry, how do we know if all those patients actually had CAPS versus some of the other entities, e.g., HU syndrome, TTP, underlying infections, malignancies, HIT, etc? Antiphospholipid antibodies have been reported in the presence of infection, and I can easily imagine a patient in a critical care unit developing septic shock with positive antiphospholipid antibodies, not necessarily having CAPS in this setting.
Article Catastrophic APS in the Context of Other Thrombotic Microangiopathies